Freeline Therapeutics raised €107M in a Series C round in Jul 2020. The company is based in Stevenage, UK. Investors in the round: Eventide Asset Management, Novo Holdings, Syncona Partners LLP and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
